Literature DB >> 16897166

Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF.

S Koch1, Ch Yao, G Grieb, P Prével, E M Noah, G C M Steffens.   

Abstract

Since the survival of ingrowing cells in biomaterials for regenerative processes largely depends on the supply of nutrients and oxygen, angiogenesis plays an important role in the development of new materials for tissue engineering. In this study we investigated the possibility of enhancing the angiogenic properties of collagen matrices by covalent incorporation of the vascular endothelial growth factor (VEGF). In a previous paper we already reported the use of homo- and heterobifunctional cross-linking agents for modifying collagen matrices [1]. In the present work the angiogenic growth factor was linked to the collagen with the homobifunctional cross-linker disuccinimidyldisuccinatepolyethyleneglycol (SS-PEG-SS) in a two step procedure. The efficiency of the first reaction step-the reaction of SS-PEG-SS with VEGF--was evaluated by western blot analysis. After 10 minutes virtually all of the dimeric molecules VEGF were on average modified by conjugation with 1 cross-linking molecule. The biological activity of the conjugate was investigated by exposing endothelial cells to non-modified VEGF and to VEGF conjugated to the cross-linker. The conjugation only had a limited effect on the mitogenic activity of VEGF. We therefore applied the cross-linking reaction to the VEGF-collagen system. In a first approach the changes were evaluated by the in vitro exposure of HUVECs to non-modified matrices, to matrices in which the VEGF was simply admixed and to matrices in which the VEGF was covalently incorporated. The angiogenic properties were evaluated in vivo with the chorioallantois membrane model. In this assay the chorioallantois membrane of the chicken embryo was exposed to the same set of matrices. The covalent incorporation of VEGF has a small but significant effect both on the formation of microvessels in the chorioallantois membrane and the tissue ingrowth into the implant. The covalent incorporation of angiogenic growth factors may thus be considered as a promising approach for enhancing the angiogenic capabilities of collagen matrices. Also the cross-linking with the homobifunctional cross-linking agent has a positive effect on the angiogenic potential of the collagen matrices.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897166     DOI: 10.1007/s10856-006-9684-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  15 in total

1.  Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors.

Authors:  M J Wissink; R Beernink; N M Scharenborg; A A Poot; G H Engbers; T Beugeling; W G van Aken; J Feijen
Journal:  J Control Release       Date:  2000-07-03       Impact factor: 9.776

2.  Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro.

Authors:  H Hall; T Baechi; J A Hubbell
Journal:  Microvasc Res       Date:  2001-11       Impact factor: 3.514

Review 3.  Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices.

Authors:  George E Davis; Kayla J Bayless; Anil Mavila
Journal:  Anat Rec       Date:  2002-11-01

4.  The chorioallantoic membrane of the chick embryo as a simple model for the study of the angiogenic and inflammatory response to biomaterials.

Authors:  G Zwadlo-Klarwasser; K Görlitz; B Hafemann; D Klee; B Klosterhalfen
Journal:  J Mater Sci Mater Med       Date:  2001-03       Impact factor: 3.896

Review 5.  The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.

Authors:  D Ribatti; A Vacca; L Roncali; F Dammacco
Journal:  Int J Dev Biol       Date:  1996-12       Impact factor: 2.203

6.  Systems for therapeutic angiogenesis in tissue engineering.

Authors:  S Soker; M Machado; A Atala
Journal:  World J Urol       Date:  2000-02       Impact factor: 4.226

7.  Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release.

Authors:  Naofumi Chinen; Masao Tanihara; Miyako Nakagawa; Keiko Shinozaki; Eriko Yamamoto; Yutaka Mizushima; Yasuo Suzuki
Journal:  J Biomed Mater Res A       Date:  2003-10-01       Impact factor: 4.396

8.  Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats.

Authors:  J S Pieper; T Hafmans; P B van Wachem; M J A van Luyn; L A Brouwer; J H Veerkamp; T H van Kuppevelt
Journal:  J Biomed Mater Res       Date:  2002-11

Review 9.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

10.  The use of bifunctional polyethyleneglycol derivatives for coupling of proteins to and cross-linking of collagen matrices.

Authors:  J-S Chen; E M Noah; N Pallua; G C M Steffens
Journal:  J Mater Sci Mater Med       Date:  2002-11       Impact factor: 3.896

View more
  20 in total

1.  Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds.

Authors:  Tania R Chan; Patrick J Stahl; S Michael Yu
Journal:  Adv Funct Mater       Date:  2011-11-22       Impact factor: 18.808

2.  Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.

Authors:  Tetsuya Hirabayashi; Haruka Takahashi; Miho Watanabe; Toshiaki Tachibana
Journal:  Hum Cell       Date:  2017-03-04       Impact factor: 4.174

Review 3.  Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials.

Authors:  James J Moon; Jennifer L West
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

4.  An approach to architecture 3D scaffold with interconnective microchannel networks inducing angiogenesis for tissue engineering.

Authors:  Jiaoxia Sun; Yuanliang Wang; Zhiyong Qian; Chenbo Hu
Journal:  J Mater Sci Mater Med       Date:  2011-08-23       Impact factor: 3.896

5.  Effect of nano-sized bioactive glass particles on the angiogenic properties of collagen based composites.

Authors:  Gabriela E Vargas; Luis A Haro Durand; Vanesa Cadena; Marcela Romero; Rosa Vera Mesones; Mirza Mačković; Stefanie Spallek; Erdmann Spiecker; Aldo R Boccaccini; Alejandro A Gorustovich
Journal:  J Mater Sci Mater Med       Date:  2013-02-22       Impact factor: 3.896

6.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

Review 7.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

8.  Evaluation of endothelialization in the center part of graft using 3 cm vascular grafts implanted in the abdominal aortae of the rat.

Authors:  Toshiharu Fukayama; Yusuke Ozai; Haruka Shimokawatoko; Yusuke Kimura; Derya Aytemiz; Ryou Tanaka; Noboru Machida; Tetsuo Asakura
Journal:  J Artif Organs       Date:  2017-05-12       Impact factor: 1.731

9.  Spatio-temporal modification of collagen scaffolds mediated by triple helical propensity.

Authors:  Allen Y Wang; Catherine A Foss; Shirley Leong; Xiao Mo; Martin G Pomper; Seungju M Yu
Journal:  Biomacromolecules       Date:  2008-06-12       Impact factor: 6.988

Review 10.  Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds.

Authors:  Andrew S Curry; Nicholas W Pensa; Abby M Barlow; Susan L Bellis
Journal:  Matrix Biol       Date:  2016-03-02       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.